Johannes Hulthe

Dr. Johannes Hulthe, MD, is an Independent Director at Lipigon Pharmaceuticals AB, an Independent Director at Guard Therapeutics International AB, a Chairman at Antaros Renostic AB and a Chief Executive Officer & Director at Antaros Medical AB.
He is on the Board of Directors at Lipigon Pharmaceuticals AB, Guard Therapeutics International AB, Antaros Medical AB, Antaros Holding AB and Metynex Pharmaceuticals AB.
Dr. Hulthe was previously employed as a Vice President by AstraZeneca AB.
He received his graduate degree from the University of Gothenburg and a doctorate degree from the University of Gothenburg.